JPH07215838A - Skin external agent - Google Patents
Skin external agentInfo
- Publication number
- JPH07215838A JPH07215838A JP6033129A JP3312994A JPH07215838A JP H07215838 A JPH07215838 A JP H07215838A JP 6033129 A JP6033129 A JP 6033129A JP 3312994 A JP3312994 A JP 3312994A JP H07215838 A JPH07215838 A JP H07215838A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- oil
- acid
- external preparation
- erythritol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004386 Erythritol Substances 0.000 claims abstract description 23
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 23
- 235000019414 erythritol Nutrition 0.000 claims abstract description 23
- 229940009714 erythritol Drugs 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 240000004371 Panax ginseng Species 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 10
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims abstract description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 8
- 239000000194 fatty acid Substances 0.000 claims abstract description 8
- 229930195729 fatty acid Natural products 0.000 claims abstract description 8
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 6
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 6
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 6
- 239000004615 ingredient Substances 0.000 claims abstract description 6
- 239000002734 clay mineral Substances 0.000 claims abstract description 5
- 229920000642 polymer Polymers 0.000 claims abstract description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 4
- 239000010696 ester oil Substances 0.000 claims abstract description 4
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 4
- 240000007474 Aloe arborescens Species 0.000 claims abstract 2
- 235000004509 Aloe arborescens Nutrition 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 28
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 13
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 9
- 241001116389 Aloe Species 0.000 claims description 8
- 235000011399 aloe vera Nutrition 0.000 claims description 8
- 244000280244 Luffa acutangula Species 0.000 claims description 7
- 241000411851 herbal medicine Species 0.000 claims description 6
- 241000219138 Luffa Species 0.000 claims description 4
- 235000003956 Luffa Nutrition 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 239000001993 wax Substances 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 244000061508 Eriobotrya japonica Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 241001092070 Eriobotrya Species 0.000 abstract description 14
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 206010013786 Dry skin Diseases 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 5
- 235000011446 Amygdalus persica Nutrition 0.000 abstract description 3
- 239000003925 fat Substances 0.000 abstract description 2
- 229920002545 silicone oil Polymers 0.000 abstract description 2
- 244000302544 Luffa aegyptiaca Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 62
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 27
- 235000019441 ethanol Nutrition 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- -1 carbon sugars Chemical class 0.000 description 13
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000004166 Lanolin Substances 0.000 description 10
- 235000019388 lanolin Nutrition 0.000 description 10
- 229940039717 lanolin Drugs 0.000 description 10
- 206010015150 Erythema Diseases 0.000 description 9
- 231100000321 erythema Toxicity 0.000 description 9
- 239000002304 perfume Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 206010039509 Scab Diseases 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 240000005809 Prunus persica Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 239000004909 Moisturizer Substances 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 230000001333 moisturizer Effects 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 229960004274 stearic acid Drugs 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 229940069521 aloe extract Drugs 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 239000000845 maltitol Substances 0.000 description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 4
- 235000010449 maltitol Nutrition 0.000 description 4
- 229940035436 maltitol Drugs 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000004204 candelilla wax Substances 0.000 description 3
- 235000013868 candelilla wax Nutrition 0.000 description 3
- 229940073532 candelilla wax Drugs 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- 235000013869 carnauba wax Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- KFEASMMSZNLDSB-UHFFFAOYSA-N 12-(12-hydroxydodecoxy)dodecan-1-ol Chemical compound OCCCCCCCCCCCCOCCCCCCCCCCCCO KFEASMMSZNLDSB-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000007788 roughening Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- CAHQGWAXKLQREW-UHFFFAOYSA-N Benzal chloride Chemical compound ClC(Cl)C1=CC=CC=C1 CAHQGWAXKLQREW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 206010011655 Cushingoid Diseases 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000000321 herbal drug Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- GXKHNMNLUFWHDR-UHFFFAOYSA-M sodium 2-[methyl(2-oxotridecyl)amino]acetate Chemical compound CCCCCCCCCCCC(=O)CN(C)CC(=O)[O-].[Na+] GXKHNMNLUFWHDR-UHFFFAOYSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は皮膚外用剤、特に、肌荒
れ改善効果が高く、使用感触の良い皮膚外用剤に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation, and more particularly to a skin external preparation having a high skin roughening improving effect and a good feeling in use.
【0002】[0002]
【従来の技術】皮膚外用剤の大きな目的は美肌状態の維
持である。美肌状態を保つためには、肌荒れを防止、改
善し、肌の皮溝、皮丘を整え、表皮細胞のターンオーバ
ーをスムーズにすることが重要であり、従来より、スキ
ンケア基剤として水分、油分を補給するクリームや乳液
が用いられたり、各種保湿剤や、ハイドロコーチゾンの
様な薬剤が配合されてきた。BACKGROUND OF THE INVENTION A major purpose of external preparations for skin is to maintain a beautiful skin condition. In order to maintain a beautiful skin condition, it is important to prevent and improve skin roughness, smooth the skin's groove and crest, and smooth the turnover of epidermal cells. Creams and emulsions for replenishing the skin have been used, and various moisturizers and agents such as hydrocortisone have been blended.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、保湿
剤、例えば多糖はアルコールの多い処方系では沈殿を生
じ、グリセリン、ソルビトール、プロピレングリコール
やコンドロイチン硫酸等は多量に配合するとべたついた
り、ほてり感があり、また、DL−スレオニン等のアミ
ノ酸では、着色、変臭などの欠点を有していた。さら
に、最も汎用される保湿剤であるグリセリン、プロピレ
ングリコールでは、多量に配合すると丘疹、面疱、紅斑
などの原因となることが、近年、知られるようになっ
た。However, moisturizers such as polysaccharides cause precipitation in a formulation system containing a large amount of alcohol, and glycerin, sorbitol, propylene glycol, chondroitin sulfate and the like have a sticky or hot feeling when mixed in a large amount. In addition, amino acids such as DL-threonine have drawbacks such as coloring and odor. Furthermore, it has become known in recent years that glycerin and propylene glycol, which are the most widely used moisturizers, cause papules, pimples, erythema and the like when mixed in large amounts.
【0004】また、ハイドロコーチゾン等の薬剤は顕著
な効果を発揮するが、ムーンフェースや、骨がもろくな
る等の副作用が報告されており、その使用が制限されて
いる。本発明は、前記従来技術の課題に鑑みなされたも
のであり、その目的は、優れた肌荒れ防止、改善効果を
有し、且つ、使用感触に優れ、また、皮膚トラブルの少
ない皮膚外用剤を提供することにある。Although drugs such as hydrocortisone exert remarkable effects, side effects such as moon face and fragility of bones have been reported, and their use is limited. The present invention has been made in view of the above-mentioned problems of the prior art, and an object thereof is to provide an excellent preparation for preventing rough skin, having an improving effect, and having an excellent feeling in use, and having less skin trouble. To do.
【0005】[0005]
【課題を解決するための手段】本発明者らは、前記目的
を達成するために鋭意研究を重ねた結果、エリスリトー
ル及び植物生薬と皮膚被覆性成分を配合した皮膚外用剤
が肌荒れ防止、改善効果に優れているばかりでなく、グ
リセリン、ソルビトールなど他の多価アルコールに見ら
れるべとつき感や丘疹、面疱、紅斑などの発生が少ない
ことを見出し、本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies for achieving the above-mentioned object, the present inventors have found that an external preparation for skin containing erythritol, a herbal medicine and a skin-covering ingredient is effective in preventing and improving skin roughness. It was found that the present invention is not only excellent, but also has less stickiness and the occurrence of papules, pimples, erythema and the like found in other polyhydric alcohols such as glycerin and sorbitol, and completed the present invention.
【0006】すなわち、本発明の請求項1記載の皮膚外
用剤はエリスリトール及び植物生薬と皮膚被覆性成分と
を配合することを特徴とする。また、本発明の請求項2
記載の皮膚外用剤は、請求項1記載の皮膚外用剤におい
て、植物生薬として植物生薬としてビワ(Eriobotrya j
aponica)、モモ(Prunus persica)、アロエ(Aloe ar
borescens)、高麗ニンジン(Panax Ginseng)、ヘチマ
(Luffa cylindrill)から抽出された天然エキスの1種
又は2種以上を配合することを特徴とする。That is, the external preparation for skin according to claim 1 of the present invention is characterized in that erythritol, a herbal medicine and a skin-covering ingredient are blended. In addition, claim 2 of the present invention
The external preparation for skin according to claim 1, which is the external preparation for skin according to claim 1, is a loquat (Eriobotrya j) as a botanical herb.
aponica), peach (Prunus persica), aloe (Aloe ar)
borescens), Korean ginseng (Panax Ginseng), and luffa cylindrill (Luffa cylindrill).
【0007】さらに、本発明の請求項3記載の皮膚外用
剤は、請求項1又は2記載の皮膚外用剤において、皮膚
被覆性成分として油脂、ロウ、炭化水素系又はシリコー
ン系の油分、脂肪酸、高級アルコール、エステル油分、
ガム質、分子量3000以上の高分子類又は粘土鉱物の
何れか1種又は2種以上を配合することを特徴とする。Further, the external preparation for skin according to claim 3 of the present invention is the external preparation for skin according to claim 1 or 2, in which oils and fats, waxes, hydrocarbon-based or silicone-based oils, fatty acids, and Higher alcohol, ester oil,
It is characterized in that any one type or two or more types of gum substance, polymers having a molecular weight of 3000 or more and clay minerals are blended.
【0008】以下本発明の構成について詳述する。本発
明に用いられるエリスリトールはメソ−エリスリトール
とも呼ばれ、天然界では地衣、担子菌、果実などに含ま
れる4炭糖の糖アルコールである。本発明におけるエリ
スリトールの配合量は皮膚外用剤全量中に0.1〜30
重量%が好ましく、さらに好ましくは1〜20重量%で
ある。0.1重量%未満では本発明の効果が十分に発揮
されず、30重量%を超えて配合しても配合量の増加に
見合った効果の増大は期待できない。The structure of the present invention will be described in detail below. Erythritol used in the present invention is also called meso-erythritol, and is a sugar alcohol of 4 carbon sugars contained in lichens, basidiomycetes, fruits and the like in the natural world. The compounding amount of erythritol in the present invention is 0.1 to 30 in the total amount of the skin external preparation.
Weight% is preferable, and 1 to 20 weight% is more preferable. If it is less than 0.1% by weight, the effect of the present invention is not sufficiently exerted, and if it exceeds 30% by weight, the effect corresponding to the increase of the compounding amount cannot be expected.
【0009】また、本発明においてエリスリトールと併
用される植物生薬としては、ビワ(Eriobotrya japonic
a)、モモ(Prunus persica)、アロエ(Aloe arboresc
ens)、高麗ニンジン(Panax Ginseng)、ヘチマ(Luff
a cylindrill)が好適である。これら植物生薬について
は、ビワ、モモ、アロエでは葉、高麗ニンジンでは根、
ヘチマでは地上部を用いるのが好ましい。また、これら
植物生薬は、粉砕したものを配合してもよいが、アルコ
ール、多価アルコール、その他の各種有機溶媒、水、水
性アルコール等の抽出溶媒で抽出された天然エキス及び
/又は抽出物をさらに精製したものを配合することが好
ましく、ビワ、モモでは1,3−ブチレングリコール
が、また、アロエ、高麗ニンジン、ヘチマではエタノー
ルが好適に用いられる。In addition, as a herbal drug used in combination with erythritol in the present invention, loquat (Eriobotrya japonic
a), peach (Prunus persica), aloe (Aloe arboresc)
ens), ginseng (Panax Ginseng), loofah (Luff
a cylindrill) is preferred. For these herbal medicines, leaves for loquat, peach and aloe, roots for ginseng,
For loofah, it is preferable to use the above-ground part. Further, these botanical herbs may be blended in a pulverized form, but a natural extract and / or an extract extracted with an extraction solvent such as alcohol, polyhydric alcohol, other various organic solvents, water or aqueous alcohol may be used. It is preferable to add a purified product, and 1,3-butylene glycol is preferably used for loquat and peach, and ethanol is preferably used for aloe, ginseng, and loofah.
【0010】本発明においてはこれら植物生薬のうち、
1種又は2種以上を配合することができる。本発明にお
ける植物生薬の配合量は皮膚外用剤全量中に0.1〜2
0重量%が好ましく、さらに好ましくは1〜10重量%
である。0.1重量%未満では本発明の効果が十分に発
揮されず、20重量%を超えて配合した場合、皮膚トラ
ブルの懸念を生じ、皮膚状態の悪化を引き起こす可能性
がある。Among these herbal medicines in the present invention,
One kind or two or more kinds can be mixed. The blending amount of the botanical herb in the present invention is 0.1 to 2 in the total amount of the external preparation for skin.
0% by weight is preferable, and 1 to 10% by weight is more preferable.
Is. If it is less than 0.1% by weight, the effect of the present invention is not sufficiently exerted, and if it exceeds 20% by weight, skin trouble may occur and the skin condition may be deteriorated.
【0011】本発明において皮膚被覆性成分とは、皮膚
上に塗布した場合に一時的にパック仕様として厚く被覆
してしまうものもあるが、一般的には薄膜状に皮膚表面
を被覆し、皮膚上の皮脂と同様の効果を期待し、水分蒸
発による肌の乾燥を防ぎ、柔軟性、弾力性を賦与し、さ
らには肌荒れ防止、肌改善をするものである。例えば、
油脂、ロウ、炭化水素系又はシリコーン系の油分、脂肪
酸、高級アルコール、エステル油分、ガム質、高分子類
又は粘土鉱物等が挙げられ、具体的に例示すれば、アボ
ガド油、トウモロコシ油、オリーブ油、ナタネ油、月見
草油、ヒマシ油、ヒマワリ油、茶実油、コメヌカ油、ホ
ホバ油、カカオ油、ヤシ油、スクワレン、スクワラン、
牛脂、モクロウ、ミツロウ、キャンデリラロウ、カルナ
バロウ、鯨ロウ、ラノリン、シリコン油、流動パラフィ
ン、セレシン、ワセリン、ポリオキシエチレン(8モ
ル)オレイルアルコールエーテル、モノオレイン酸グリ
セリル等の油分、カプリルアルコール、ラウリルアルコ
ール、ミリスチルアルコール、セチルアルコール等の高
級アルコール、コレステロール、フィトステロール等の
ステロール、カプリン酸、ラウリン酸、ミリスチン酸、
パルミチン酸、ステアリン酸、ベヘニン酸、ラノリン脂
肪酸、リノール酸、リノレン酸等の高級脂肪酸、メチル
セルロース、エチルセルロース、ポリビニルアルコール
等の分子量3000以上の高分子類、モンモリロナイ
ト、ラポナイト等の粘土鉱物、アラビアガム、ヴィーガ
ム、グアーガム等のガム質等が挙げられる。[0011] In the present invention, the skin-covering component may temporarily thicken as a pack specification when it is applied on the skin, but in general, it covers the skin surface in a thin film form, Expected to have the same effect as the above sebum, it prevents the skin from drying due to water evaporation, imparts flexibility and elasticity, and further prevents rough skin and improves the skin. For example,
Fats and oils, waxes, hydrocarbon-based or silicone-based oils, fatty acids, higher alcohols, ester oils, gums, polymers or clay minerals, and the like, specifically, avocado oil, corn oil, olive oil, Rapeseed oil, evening primrose oil, castor oil, sunflower oil, tea seed oil, rice bran oil, jojoba oil, cacao oil, coconut oil, squalene, squalane,
Beef tallow, owl, beeswax, candelilla wax, carnauba wax, whale wax, lanolin, silicone oil, liquid paraffin, ceresin, vaseline, polyoxyethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, etc., capryl alcohol, lauryl Alcohol, higher alcohols such as myristyl alcohol and cetyl alcohol, sterols such as cholesterol and phytosterol, capric acid, lauric acid, myristic acid,
Higher fatty acids such as palmitic acid, stearic acid, behenic acid, lanolin fatty acid, linoleic acid and linolenic acid, polymers having a molecular weight of 3000 or more such as methyl cellulose, ethyl cellulose and polyvinyl alcohol, clay minerals such as montmorillonite and laponite, gum arabic and vigum , Gums such as guar gum, and the like.
【0012】本発明の皮膚外用剤においては、エリスリ
トール及び前記植物生薬と、皮膚被覆性成分とを併用す
ることにより、それぞれ単独で使用した場合に比して肌
荒れ改善効果が相乗的に向上する。本発明の皮膚外用剤
は化粧料、医薬品、医薬部外品等、外皮に適用されるも
のを指し、その剤型は水溶液系、可溶化系、乳化系、粉
末系、油液系、ゲル系、軟膏系、水−油2層系、水−油
−粉末3層系等幅広い形態を取り得る。In the external preparation for skin of the present invention, the combined use of erythritol and the above-mentioned plant crude drug and the skin-covering component synergistically improves the rough skin improving effect as compared with the case where they are used alone. The external preparation for skin of the present invention refers to cosmetics, pharmaceuticals, quasi drugs, etc. applied to the outer skin, and its dosage form is an aqueous solution-based, solubilized-based, emulsion-based, powder-based, oil-based, gel-based system. , An ointment system, a water-oil two-layer system, a water-oil-powder three-layer system, and the like.
【0013】本発明の皮膚外用剤には上記必須成分の他
に通常化粧料や医薬品等の皮膚外用剤に用いられる他の
成分を本発明の効果を損なわない範囲で配合することが
できる。例えば、二酸化チタン、マイカ、タルク等の粉
末成分、パラアミノ安息香酸、ホモメンチル−7N−ア
セチルアラントラニレート、ブチルメトキシベンゾイル
メタン、ジ−パラメトキシケイ皮酸−モノ−2−エチル
ヘキサン酸グリセリル、アミルサリシレート、オクチル
シンナメート、2,4−ジヒドロキシベンゾフェノン等
の紫外線吸収剤、ポリエチレングリコール、グリセリ
ン、ソルビトール、キシリトール、マルチトール等の保
湿剤、エタノール、1,3−ブチレングリコール等の有
機溶剤、ブチルヒドロキシトルエン、トコフェロール、
フィチン酸等の酸化防止剤、安息香酸、サリチル酸、ソ
ルビン酸、パラオキシ安息香酸アルキルエステル(エチ
ルパラベン、ブチルパラベン等)、ヘキサクロロフェン
等の抗菌防腐剤、グリシン、アラニン、バリン、ロイシ
ン、セリン、トレオニン、フェニルアラニン、チロシ
ン、アスパラギン酸、アスパラギン、グルタミン、タウ
リン、アルギニン、ヒスチジン等のアミノ酸及びこれら
のアルカリ金属塩と塩酸塩、アシルサルコシン酸(例え
ばラウロイルメチルサルコシンナトリウム等)、グルタ
チオン、クエン酸、リンゴ酸、酒石酸、乳酸等の有機
酸、ビタミンA及びその誘導体、ビタミンB6塩酸塩、
ビタミンB6トリパルミテート、ビタミンB6ジオクタノ
エート、ビタミンB2及びその誘導体、ビタミンB12、
ビタミンB15及びその誘導体等のビタミンB類、アスコ
ルビン酸、アスコルビン酸硫酸エステル(塩)、アスコ
ルビン酸リン酸エステル(塩)、アスコルビン酸ジパル
ミテート等のビタミンC類、α−トコフェロール、β−
トコフェロール、γ−トコフェロール、ビタミンEアセ
テート、ビタミンEニコチネート等のビタミンE類、ビ
タミンD類、ビタミンH、パントテン酸、パンテチン等
のビタミン類、ニコチン酸アミド、ニコチン酸ベンジ
ル、γ−オリザノール、アラントイン、グリチルリチン
酸(塩)、グリチルレチン酸及びその誘導体、ヒノキチ
オール、ムシジン、ビサボロール、ユーカリプトール、
チモール、イノシトール、サポニン類(サイコサポニ
ン、ニンジンサポニン、ヘチマサポニン、ムクロジサポ
ニン等)、パントテニルエチルエーテル、エチニルエス
トラジオール、セファランチン、プラセンタエキス等の
各種薬剤、ギシギシ、クララ、コウホネ、オレンジ、セ
ージ、ノコギリソウ、ゼニアオイ、センキュウ、センブ
リ、タイム、トウキ、トウヒ、バーチ、スギナ、ヘチ
マ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、
シャクヤク、アロエ、クチナシ、サワラ等の植物の有機
溶媒、アルコール、多価アルコール、水、水性アルコー
ル等で抽出した天然エキス、色素、モノラウリン酸ソル
ビタン、モノパルミチン酸ソルビタン、セスキオレイン
酸ソルビタン、トリオレイン酸ソルビタン、モノラウリ
ン酸ポリオキシエチレンソルビタン、モノステアリン酸
ポリオキシエチレンソルビタン、ポリエチレングリコー
ルモノオレエート、ポリオキシエチレンアルキルエーテ
ル、ポリグリコールジエステル、ラウロイルジエタノー
ルアマイド、脂肪酸イソプロパノールアマイド、マルチ
トールヒドロキシ脂肪族エーテル、アルキル化多糖、ア
ルキルグルコシド、シュガーエステル等の非イオン性界
面活性剤、ステアリルトリメチルアンモニウムクロライ
ド、塩化ベンザルコニウム、ラウリルアミンオキサイド
等のカチオン性界面活性剤、パルミチン酸ナトリウム、
ラウリン酸ナトリウム、ラウリル硫酸ナトリウム、ラウ
リル硫酸カリウム、アルキル硫酸トリエタノールアミン
エーテル、ロート油、リニアドデシルベンゼン硫酸、ポ
リオキシエチレン硬化ヒマシ油マレイン酸、アシルメチ
ルタウリン等のアニオン性界面活剤、両性界面活性剤、
香料、精製水等を配合することができる。In addition to the above-mentioned essential components, the external preparation for skin of the present invention may contain other components which are usually used in external preparations for skin such as cosmetics and pharmaceuticals within a range that does not impair the effects of the present invention. For example, powder components such as titanium dioxide, mica, talc, para-aminobenzoic acid, homomenthyl-7N-acetylalanthranilate, butylmethoxybenzoylmethane, di-paramethoxycinnamic acid-glyceryl mono-2-ethylhexanoate, amyl salicylate. UV absorbers such as octyl cinnamate and 2,4-dihydroxybenzophenone, moisturizers such as polyethylene glycol, glycerin, sorbitol, xylitol and maltitol, organic solvents such as ethanol and 1,3-butylene glycol, butylhydroxytoluene, Tocopherol,
Antioxidants such as phytic acid, benzoic acid, salicylic acid, sorbic acid, alkyl esters of paraoxybenzoic acid (ethyl paraben, butyl paraben, etc.), antibacterial preservatives such as hexachlorophene, glycine, alanine, valine, leucine, serine, threonine, Amino acids such as phenylalanine, tyrosine, aspartic acid, asparagine, glutamine, taurine, arginine and histidine, and their alkali metal salts and hydrochlorides, acylsarcosine acid (eg sodium lauroylmethylsarcosinate), glutathione, citric acid, malic acid, tartaric acid. , Organic acids such as lactic acid, vitamin A and its derivatives, vitamin B 6 hydrochloride,
Vitamin B 6 tripalmitate, Vitamin B 6 dioctanoate, Vitamin B 2 and its derivatives, Vitamin B 12 ,
Vitamin B 15 and its derivatives such as vitamin B, ascorbic acid, ascorbic acid sulfate (salt), ascorbic acid phosphate (salt), ascorbic acid dipalmitate and other vitamin Cs, α-tocopherol, β-
Vitamin Es such as tocopherol, γ-tocopherol, vitamin E acetate, vitamin E nicotinate, vitamins D, vitamin H, pantothenic acid, vitamins such as pantethine, nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizin Acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol,
Thymol, inositol, saponins (saikosaponin, carrot saponin, hemimasaponin, muclodisaponin, etc.), pantothenyl ether, ethinyl estradiol, cepharantin, placenta extract, etc. Mallow, senkyu, senburi, thyme, touki, spruce, birch, horsetail, loofah, horse chestnut, yukinoshita, arnica, lily, mugwort,
Natural extracts extracted with organic solvents of plants such as peony, aloe, gardenia, and mackerel, alcohol, polyhydric alcohol, water, aqueous alcohol, pigments, sorbitan monolaurate, sorbitan monopalmitate, sorbitan sesquioleate, trioleate Sorbitan, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monostearate, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol diester, lauroyl diethanol amide, fatty acid isopropanol amide, maltitol hydroxy aliphatic ether, alkylation Nonionic surfactants such as polysaccharides, alkyl glucosides, sugar esters, stearyl trimethyl ammonium chloride, benzal chloride Chloride, cationic surfactants such as lauryl amine oxide, sodium palmitate,
Sodium laurate, sodium lauryl sulphate, potassium lauryl sulphate, alkylsulfuric acid triethanolamine ether, funnel oil, linear dodecyl benzene sulphate, polyoxyethylene hydrogenated castor oil maleic acid, anionic surfactants such as acylmethyltaurine, amphoteric surfactant Agent,
Fragrances, purified water and the like can be added.
【0014】[0014]
【実施例】以下に実施例を挙げて本発明を具体的に説明
するが、本発明はこれらに限定されるものではない。
尚、配合量については、他に指定のない限り重量%で表
わす。 〔肌荒れ改善試験〕健常人男性の背部皮膚を3%のドデ
シル硫酸ナトリウム水溶液で処理し、肌荒れを作製し
た。2時間後、各試料を20μl開放塗布した。これを
5日間繰り返し、6日目に目視により肌荒れの状態を観
察し、表1の基準に従って採点した。評点が高いほど肌
荒れ改善効果が高いことを示す。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
In addition, the compounding amount is expressed in% by weight unless otherwise specified. [Rough skin improvement test] The back skin of a healthy man was treated with a 3% sodium dodecyl sulfate aqueous solution to prepare rough skin. After 2 hours, 20 μl of each sample was applied in an open manner. This was repeated for 5 days, and on the 6th day, the state of rough skin was visually observed and scored according to the criteria in Table 1. The higher the score, the higher the effect of improving rough skin.
【0015】[0015]
【表1】 ─────────────────────────────────── 評点 評 点 の 基 準 ─────────────────────────────────── 1 広範囲の角層の乾燥、めくれ、強い紅斑を認める。 2 角層の乾燥、めくれ、中程度の紅斑を認める。 3 角層の乾燥は認められるが、めくれは認められない。 弱い紅斑を認める。 4 角層の乾燥、めくれは認められないが、若干の紅斑を認める。 5 角層の乾燥、めくれ、紅斑共に認められない。 ───────────────────────────────────[Table 1] ─────────────────────────────────── Scores Standards of scores ───── ────────────────────────────── 1 A wide range of horny layer dryness, swelling, and strong erythema are observed. 2 Dry, swelling and moderate erythema on the stratum corneum. 3 Dryness of the stratum corneum is observed, but no curling is observed. Weak erythema. 4 Dryness and turning of the stratum corneum are not observed, but some erythema is observed. 5 Dryness, swelling and erythema of the stratum corneum are not observed. ───────────────────────────────────
【0016】男性パネルは各群10人とし、10人の評
点の平均値を基に、各試料の肌荒れ改善効果を判定し
た。判定 ◎:評点の平均が4以上 ○:評点の平均が3以上4未満 △:評点の平均が2以上3未満 ×:評点の平均が2未満The male panel was made up of 10 persons in each group, and the rough skin improving effect of each sample was judged based on the average value of the scores of 10 persons. Judgment ◎: Average score is 4 or more ○: Average score is 3 or more and less than 4 Δ: Average score is 2 or more and less than 3 ×: Average score is less than 2
【0017】[0017]
【表2】 ──────────────────────────────────── 試料 1 2 3 4 5 6 ──────────────────────────────────── エリスリトール 10 8 6 4 2 0 ビワの葉エキス 0 2 4 6 8 10ハイト゛ロキシフ゜ロヒ゜ルセルロース 0.5 0.5 0.5 0.5 0.5 0.5 精製水 残 余 ──────────────────────────────────── 評価 △ ○ ○ ○ ○ △ ────────────────────────────────────[Table 2] ──────────────────────────────────── Sample 1 2 3 4 5 6 6 ─── ───────────────────────────────── Erythritol 10 8 6 4 2 0 Loquat leaf extract 0 2 4 6 8 10 Hydroxypropyl cellulose 0.5 0.5 0.5 0.5 0.5 0.5 Purified water Residue ──────────────────────────────────── Evaluation △ ○ ○ ○ ○ △ ─────────────────────────────────────
【0018】表2より、皮膚被覆性成分(ハイドロキシ
プロピルセルロース)とエリスリトール又は植物生薬
(ビワの葉エキス)の2者併用では肌荒れ改善効果がほ
とんど認められないが、これら3者を併用した系では肌
荒れ改善効果が相乗的に増大することが理解される。From Table 2, it can be seen that the combination of the skin-covering component (hydroxypropyl cellulose) and erythritol or the botanical herb medicine (loquat leaf extract) does not substantially improve the rough skin, but the combination of these three compounds is effective. It is understood that the rough skin improving effect is synergistically increased.
【0019】次に、下記表3に示す処方で皮膚外用剤を
調製し、前記同様の肌荒れ改善試験を行った。また、同
時に使用感についても調査した。尚、使用感の評価基準
は下記の通りである。 ◎:べたつき感がない ○:べたつき感がほとんどない △:ややべたつく ×:べたつくNext, a skin external preparation was prepared according to the formulation shown in Table 3 below, and the same rough skin improvement test as described above was conducted. At the same time, the usability was also investigated. The evaluation criteria for the feeling of use are as follows. ◎: No sticky feeling ○: Almost no sticky feeling △: Slightly sticky ×: Sticky
【0020】[0020]
【表3】 ──────────────────────────────────── 試料 7 8 9 10 11 12 13 14 ──────────────────────────────────── グリセリン 5 15 20 30 − − − − エリスリトール − − − − 5 15 20 30 ビワの葉エキス 5 15 20 20 5 15 20 20 ベントナイト 5 5 5 5 5 5 5 5 ラノリンアルコール 1 1 1 1 1 1 1 1 POE(50)硬化ヒマシ油 1 1 1 1 1 1 1 1 精製水 残 余 ──────────────────────────────────── 肌荒れ防止効果 △ ○ ◎ ◎ ○ ◎ ◎ ◎ 使用感 ◎ ○ ○ × ◎ ◎ ◎ ○ ────────────────────────────────────[Table 3] ──────────────────────────────────── Sample 7 8 9 9 10 11 12 12 13 14 ─ ─────────────────────────────────── Glycerin 5 15 20 30 30 − − − − Erythritol − − − − 5 15 20 30 Loquat leaf extract 5 15 20 20 20 5 15 20 20 Bentonite 5 5 5 5 5 5 5 5 5 5 Lanolin alcohol 1 1 1 1 1 1 1 1 1 POE (50) hydrogenated castor oil 1 1 1 1 1 1 1 1 1 1 Purification Water residue ──────────────────────────────────── Rough skin prevention effect △ ○ ◎ ◎ ○ ◎ ◎ ◎ ◎ Usability ◎ ○ ○ × ◎ ◎ ◎ ○ ─────────────────────────────────────
【0021】表3より、従来の保湿剤(グリセリン)を
用いると肌荒れ改善効果を有するものの高濃度ではべた
つき感があった。一方、エリスルトール及び植物生薬と
皮膚被覆性成分とを併用した系では高濃度においてもべ
たつき感はなく、肌荒れ改善効果に優れていた。As shown in Table 3, when the conventional moisturizer (glycerin) was used, it had an effect of improving rough skin, but it had a sticky feeling at high concentrations. On the other hand, the system in which erythritol or a botanical herb and a skin-covering ingredient were used in combination had no sticky feeling even at a high concentration, and was excellent in the effect of improving rough skin.
【0022】[0022]
【表4】 ──────────────────────────────────── 試料 15 16 17 18 19 20 21 22 ──────────────────────────────────── エリスリトール − − − − 10 10 10 10 モモの葉エキス 10 − − − 10 − − − アロエエキス − 10 − − − 10 − − 高麗ニンジンエキス − − 10 − − − 10 − ヘチマエキス − − − 10 − − − 10 ベントナイト 5 5 5 5 5 5 5 5 ラノリンアルコール 1 1 1 1 1 1 1 1 POE(50)硬化ヒマシ油 1 1 1 1 1 1 1 1 水 残 余 ──────────────────────────────────── 肌荒れ防止効果 △ △ △ △ ◎ ◎ ◎ ◎ ──────────────────────────────────── 表4より、皮膚被覆性成分とエリスリトールと各種植物
生薬の併用系において、肌荒れ改善効果を有することが
理解される。[Table 4] ──────────────────────────────────── Sample 15 16 17 18 18 19 20 21 22 22 ─ ─────────────────────────────────── Erythritol − − − − 10 10 10 10 Peach leaf extract 10 − −−10 −−− Aloe extract −10 −−−− 10−− Korean ginseng extract −−− 10 −−− 10− Luffa extract −−− 10 −−−− 10 Bentonite 5 5 5 5 5 5 5 5 5 Lanolin alcohol 11 1 1 1 1 1 1 1 POE (50) hydrogenated castor oil 1 1 1 1 1 1 1 1 1 water residual balance ────────────────────────── ────────── Skin roughening prevention effect △ △ △ △ ◎ ◎ ◎ ◎ ◎ ─────────────────── ───────────────── from Table 4, in the skin covering component and the combination system of erythritol and various plant crude drugs, is understood to have a rough skin improving effect.
【0023】〔レプリカ法による実使用試験〕健康な女
性パネラーの顔面の皮膚表面形態をシリコーン樹脂によ
るレプリカ法を用いて肌のレプリカを採り、顕微鏡(1
7倍)にて観察した。皮紋の状態及び角層の剥離状態か
ら、表5に示す基準に基づいて肌荒れを評価し、評点が
1又は2と判断されたパネラーを1群20名とし、顔面
の右半分に表6記載の配合例1又は配合例2のローショ
ンを、左半分に比較例1のローションをそれぞれ1日2
回塗布した。2週間後、再びレプリカを採り、肌の状態
を観察、前記と同様に評価した。[Actual Use Test by Replica Method] The skin surface morphology of the face of a healthy female panelist is replicated using a silicone resin replica method, and a microscope (1
7 times). Rough skin was evaluated based on the criteria shown in Table 5 from the state of the skin pattern and the peeling state of the stratum corneum, and the panelists judged to have a score of 1 or 2 were set to 20 people per group, and Table 6 is shown on the right half of the face. Lotion of Formulation Example 1 or Formulation 2 of Comparative Example 1 was applied to the left half for 2 days each.
It was applied twice. Two weeks later, a replica was taken again and the skin condition was observed and evaluated in the same manner as above.
【0024】[0024]
【表5】 ─────────────────────────────────── 評点 評 点 の 基 準 ─────────────────────────────────── 1 皮溝、皮丘の消失、広範囲の角層のめくれが認められる 2 皮溝、皮丘が不鮮明、角層のめくれが認められる 3 皮溝、皮丘は認められるが、平坦 4 皮溝、皮丘が鮮明 5 皮溝、皮丘が鮮明で整っている ───────────────────────────────────[Table 5] ─────────────────────────────────── Scores Standards of scores ───── ────────────────────────────── 1 Skin clefts, disappearance of cuticles, and wide skin keratinization 2 skins Grooves and crusts are unclear, and horny layer is turned up. 3 Crusts and crusts are observed, but flat 4 Crusts, crusts are clear 5 Crusts, crusts are clear and regular ──── ───────────────────────────────
【0025】各群において、肌荒れ改善効果を次のよう
に判定した。判定 ○:評点が4又は5と評価されたパネラーの割合が75
%以上 △:評点が4又は5と評価されたパネラーの割合が25
%以上75%未満 ×:評点が4又は5と評価されたパネラーの割合が25
%未満結果を表6に示す。In each group, the rough skin improving effect was judged as follows. Judgment ○: The proportion of panelists who were evaluated as 4 or 5 is 75
% Or more △: The proportion of panelists evaluated as 4 or 5 is 25
% Or more and less than 75% x: The proportion of panelists evaluated as 4 or 5 is 25
The results of less than% are shown in Table 6.
【0026】[0026]
【表6】 ─────────────────────────────────── 成分 配合例1 配合例2 比較例1 ─────────────────────────────────── エリスリトール 1.5 1.5 − モモの葉エキス 1.5 − − ヘチマエキス − 1.5 − グリセリン − − 3.0 スクワラン 2.0 2.0 2.0 プロピレングリコール 1.0 1.0 1.0 クエン酸 0.2 0.2 0.2 95%エタノール 10.0 10.0 10.0 POE(20)ラウリルエーテル 0.5 0.5 0.5 香料 適量 適量 適量 精製水 残余 残余 残余 ─────────────────────────────────── 評価 ○ ○ △ ─────────────────────────────────── 表6から判るように、本発明にかかる皮膚外用剤は肌荒
れ改善効果に優れた皮膚外用剤である。[Table 6] ─────────────────────────────────── Component Composition example 1 Composition example 2 Comparative example 1 ─ ────────────────────────────────── Erythritol 1.5 1.5 − Peach leaf extract 1.5 − − Loofah extract − 1.5 − Glycerin − − 3.0 Squalane 2.0 2.0 2.0 Propylene glycol 1.0 1.0 1.0 Citric acid 0.2 0.2 0.2 95% Ethanol 10.0 10.0 10.0 POE (20) Lauryl ether 0.5 0.5 0.5 Perfume proper amount proper amount Purified water Residual residue Residual residue ──────── ─────────────────────────── Evaluation ○ ○ △ ──────────────────── ──────────────── As can be seen from Table 6, the external preparation for skin according to the present invention is an external preparation for skin which is excellent in improving rough skin. .
【0027】以下の配合例3〜11の皮膚外用剤を常法
により調製したところ、何れも肌荒れ防止、改善効果を
有し、使用感も良好で、また、丘疹、面疱、濃疱、紅斑
等を発生することがない安全性の高い皮膚外用剤であっ
た。When the external preparations for the skin of the following formulation examples 3 to 11 were prepared by a conventional method, they all had the effects of preventing and improving skin roughness, and had a good feeling in use, and also had papules, pimples, blister and erythema. It was a highly safe external preparation for the skin that did not cause the above.
【0028】配合例3 パック カオリン 70.8wt% タルク 23.0 プロピレングリコール 5.0 酢酸カルシウム 0.01 尿素 0.5 エリスリトール 0.3 ビワの葉エキス 0.1 香料 適 量 Formulation 3 Pack Kaolin 70.8 wt% Talc 23.0 Propylene glycol 5.0 Calcium acetate 0.01 Urea 0.5 Erythritol 0.3 Loquat leaf extract 0.1 Perfume Suitable amount
【0029】配合例4 栄養クリーム ステアリン酸 2.0wt% ステアリルアルコール 7.0 還元ラノリン 2.0 スクワラン 5.0 オクチルドデカノール 6.0 マルチトールヒドロキシラウリルエーテル 3.0 グリセリルモノステアレート 2.0 防腐剤 適 量 香料 適 量 プロピレングリコール 5.0 エリスリトール 8.0 ビワの葉エキス 0.2 シンホングギニンジンエキス 0.1 精製水 残 余 Formulation Example 4 Nourishing Cream Stearic Acid 2.0 wt% Stearyl Alcohol 7.0 Reduced Lanolin 2.0 Squalane 5.0 Octyldodecanol 6.0 Maltitol Hydroxylauryl Ether 3.0 Glyceryl Monostearate 2.0 Preservative Agent Adequate amount Perfume Adequate amount Propylene glycol 5.0 Erythritol 8.0 Loquat leaf extract 0.2 Singhhong Ginseng extract 0.1 Purified water Residual
【0030】配合例5 リップトリートメント キャンデリラロウ 9.0wt% 固形パラフィン 8.0 ミツロウ 5.0 カルナバロウ 5.0 ラノリン 11.0 ヒマシ油 残 余 エリスリトール 18.0 モモの葉エキス 10.0 イソプロピルミリステート 10.0 ショ糖脂肪酸エステル 2.0 香料 適 量 酸化防止剤 残 余 Blending Example 5 Lip Treatment Candelilla Wax 9.0 wt% Solid Paraffin 8.0 Beeswax 5.0 Carnauba Wax 5.0 Lanolin 11.0 Castor Oil Residual Erythritol 18.0 Peach Leaf Extract 10.0 Isopropyl myristate 10.0 Sucrose fatty acid ester 2.0 Fragrance Suitable amount Antioxidant Residual
【0031】配合例6 乳液 ステアリン酸 2.0wt% セタノール 1.0 ワセリン 3.0 ラノリンアルコール 2.0 流動パラフィン 8.0 スクワラン 2.0 パラジメチルアミノ安息香酸2−エチルヘキシル 2.0 エリスリトール 10.0 アロエエキス 0.5 ポリオキシエチレン(10)モノオレエート 2.5 トリエタノールアミン 1.0 プロピレングリコール 5.0 防腐剤 適 量 香料 適 量 精製水 残 余 Formulation 6 Emulsion stearic acid 2.0 wt% Cetanol 1.0 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin 8.0 Squalane 2.0 2-Ethylhexyl paradimethylaminobenzoate 2.0 Erythritol 10.0 Aloe extract 0.5 Polyoxyethylene (10) monooleate 2.5 Triethanolamine 1.0 Propylene glycol 5.0 Preservative A suitable amount Perfume Suitable amount Purified water Residual
【0032】配合例7 乳液 ステアリン酸 2.0wt% セタノール 1.0 ワセリン 3.0 ラノリンアルコール 2.0 流動パラフィン 8.0 スクワラン 2.0 オクチルメトキシシンナメート 2.0 エリスリトール 5.0 高麗ニンジンエキス 2.0 ビワの葉エキス 3.0 ポリオキシエチレン(10)モノオレエート 2.5 トリエタノールアミン 1.0 プロピレングリコール 5.0 防腐剤 適 量 香料 適 量 精製水 残 余 Formulation Example 7 Emulsion Stearic acid 2.0 wt% Cetanol 1.0 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin 8.0 Squalane 2.0 Octyl methoxycinnamate 2.0 Erythritol 5.0 Ginseng extract 2 0.0 Loquat leaf extract 3.0 Polyoxyethylene (10) monooleate 2.5 Triethanolamine 1.0 Propylene glycol 5.0 Preservatives proper amount Perfume proper amount Purified water Residue
【0033】配合例8 栄養クリーム ステアリン酸 2.0wt% ステアリルアルコール 7.0 還元ラノリン 2.0 スクワラン 5.0 オクチルドデカノール 6.0 マルチトールヒドロキシラウリルエーテル 3.0 グリセリルモノステアレート 2.0 防腐剤 適 量 香料 適 量 プロピレングリコール 5.0 エリスリトール 1.0 モモの葉エキス 0.5 ビワの葉エキス 0.3 精製水 残 余 Formulation Example 8 Nourishing Cream Stearic Acid 2.0 wt% Stearyl Alcohol 7.0 Reduced Lanolin 2.0 Squalane 5.0 Octyldodecanol 6.0 Maltitol Hydroxylauryl Ether 3.0 Glyceryl Monostearate 2.0 Preservative Agent Suitable amount Perfume Suitable amount Propylene glycol 5.0 Erythritol 1.0 Peach leaf extract 0.5 Loquat leaf extract 0.3 Purified water Residual
【0034】配合例9 パック カオリン 65.0wt% タルク 19.0 プロピレングリコール 5.0 酢酸カルシウム 0.01 尿素 0.5 エリスリトール 0.2 モモの葉エキス 0.3 アロエエキス 0.3 香料 適 量 Formulation 9 Pack Kaolin 65.0 wt% Talc 19.0 Propylene glycol 5.0 Calcium acetate 0.01 Urea 0.5 Erythritol 0.2 Peach leaf extract 0.3 Aloe extract 0.3 Perfume Suitable amount
【0035】配合例10 リップトリートメント キャンデリラロウ 9.0wt% 固形パラフィン 8.0 ミツロウ 5.0 カルナバロウ 5.0 ラノリン 11.0 ヒマシ油 残 余 エリスリトール 20.0 ヘチマエキス 15.0 アロエエキス 10.0 イソプロピルミリステート 10.0 POE(60)硬化ヒマシ油 2.0 香料 適 量 酸化防止剤 残 余 Formulation 10 Lip Treatment Candelilla Wax 9.0 wt% Solid Paraffin 8.0 Beeswax 5.0 Carnauba Wax 5.0 Lanolin 11.0 Castor Oil Residual Erythritol 20.0 Loofah Extract 15.0 Aloe Extract 10.0 Isopropyl myristate 10.0 POE (60) hydrogenated castor oil 2.0 Perfume proper amount antioxidant remaining
【0036】[0036]
【発明の効果】本発明の皮膚外用剤は、肌荒れ改善・予
防効果に優れ、また、丘疹、面疱、濃疱、紅斑等を発生
することがなく、使用感にも優れた皮膚外用剤である。The external preparation for skin of the present invention is an external preparation for skin which is excellent in improving and preventing skin roughness, does not cause papules, blisters, vesicles, erythema, etc. is there.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/78 ADA W 8217−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location A61K 35/78 ADA W 8217-4C
Claims (3)
性成分を配合することを特徴とする皮膚外用剤。1. An external preparation for skin comprising erythritol, a herbal medicine and a skin-covering ingredient.
物生薬としてビワ(Eriobotrya japonica)、モモ(Pru
nus persica)、アロエ(Aloe arborescens)、高麗ニ
ンジン(Panax Ginseng)、ヘチマ(Luffa cylindril
l)から抽出された天然エキスの1種又は2種以上を配
合することを特徴とする皮膚外用剤。2. The external preparation for skin according to claim 1, wherein loquat (Eriobotrya japonica) and peach (Pru) are used as herbal medicines.
nus persica), aloe (Aloe arborescens), ginseng (Panax Ginseng), loofah (Luffa cylindril)
An external preparation for skin, comprising one or more natural extracts extracted from l).
て、皮膚被覆性成分として、油脂、ロウ、炭化水素系又
はシリコーン系の油分、脂肪酸、高級アルコール、エス
テル油分、ガム質、分子量3000以上の高分子類又は
粘土鉱物の何れか1種又は2種以上を配合することを特
徴とする皮膚外用剤。3. The external skin preparation according to claim 1 or 2, wherein the skin-covering ingredient is oil, wax, hydrocarbon-based or silicone-based oil, fatty acid, higher alcohol, ester oil, gum, molecular weight of 3000 or more. An external preparation for skin, characterized in that any one kind or two or more kinds of the polymers or the clay minerals mentioned above is blended.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6033129A JPH07215838A (en) | 1994-02-04 | 1994-02-04 | Skin external agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6033129A JPH07215838A (en) | 1994-02-04 | 1994-02-04 | Skin external agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07215838A true JPH07215838A (en) | 1995-08-15 |
Family
ID=12378004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6033129A Pending JPH07215838A (en) | 1994-02-04 | 1994-02-04 | Skin external agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07215838A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2742987A1 (en) * | 1996-01-03 | 1997-07-04 | Lvmh Rech | USE IN THE FIELD OF COSMETICS AND PHARMACY, IN PARTICULAR DERMATOLOGY, OF AN EXTRACT FROM ERIOBOTRYA JAPONICA FOR STIMULATING THE SYNTHESIS OF GLYCOSAMINOGLYCANS |
| JPH1036279A (en) * | 1996-07-18 | 1998-02-10 | Ichimaru Pharcos Co Ltd | Fibroblast proliferation promoting agent containing vegetable extract |
| EP0790817A4 (en) * | 1994-11-02 | 2000-03-08 | Procter & Gamble | COSMETIC COMPOSITIONS |
| KR100281001B1 (en) * | 1998-04-22 | 2001-02-01 | 김윤종 | Method of manufacturing skin replenishment liquid based on ginseng |
| KR20020012915A (en) * | 2000-08-09 | 2002-02-20 | 유상옥,송운한 | Persicae Flos extract-containing composition for skin-protection against UV |
| JP2002226385A (en) * | 2001-02-01 | 2002-08-14 | Mareyoshi Sawaguchi | Medicine composition for oral cavity and external use |
| KR100358590B1 (en) * | 2000-07-10 | 2002-10-25 | 로제화장품 주식회사 | Cosmetic composition including bupleurum and/or plunus abstracts |
| EP3058945A3 (en) * | 2015-02-19 | 2016-09-21 | Hiantis S.r.l. | Pharmaceutical compositions and formulations for topical application with astringent and antimicrobial effect |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58113116A (en) * | 1981-12-26 | 1983-07-05 | Mutsuko Kurita | Cosmetic |
| JPS63230624A (en) * | 1987-03-18 | 1988-09-27 | Earth Chem Corp Ltd | Bath liquid |
| JPH02231408A (en) * | 1989-03-06 | 1990-09-13 | Lion Corp | Novel skin drug for external use |
| JPH03188008A (en) * | 1989-12-15 | 1991-08-16 | Shiseido Co Ltd | Cosmetic |
| JPH0429919A (en) * | 1990-05-25 | 1992-01-31 | Sunstar Inc | Moisture-retaining cosmetic |
| JPH04124118A (en) * | 1990-09-14 | 1992-04-24 | Shiseido Co Ltd | Skin external preparation |
| JPH04334308A (en) * | 1991-05-10 | 1992-11-20 | Kanebo Ltd | Skin cosmetic |
-
1994
- 1994-02-04 JP JP6033129A patent/JPH07215838A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58113116A (en) * | 1981-12-26 | 1983-07-05 | Mutsuko Kurita | Cosmetic |
| JPS63230624A (en) * | 1987-03-18 | 1988-09-27 | Earth Chem Corp Ltd | Bath liquid |
| JPH02231408A (en) * | 1989-03-06 | 1990-09-13 | Lion Corp | Novel skin drug for external use |
| JPH03188008A (en) * | 1989-12-15 | 1991-08-16 | Shiseido Co Ltd | Cosmetic |
| JPH0429919A (en) * | 1990-05-25 | 1992-01-31 | Sunstar Inc | Moisture-retaining cosmetic |
| JPH04124118A (en) * | 1990-09-14 | 1992-04-24 | Shiseido Co Ltd | Skin external preparation |
| JPH04334308A (en) * | 1991-05-10 | 1992-11-20 | Kanebo Ltd | Skin cosmetic |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0790817A4 (en) * | 1994-11-02 | 2000-03-08 | Procter & Gamble | COSMETIC COMPOSITIONS |
| US5955083A (en) * | 1996-01-03 | 1999-09-21 | Lvmh Recherche | Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis |
| BE1010042A3 (en) * | 1996-01-03 | 1997-12-02 | Lvmh Rech | USE OF AN EXTRACT loquat, PARTICULARLY IN THE FIELD OF COSMETICS, TO STIMULATE THE SUMMARY OF GLYCOSAMINOGLYCANS. |
| GB2314272A (en) * | 1996-01-03 | 1997-12-24 | Lvmh Rech | Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis |
| ES2129014A1 (en) * | 1996-01-03 | 1999-05-16 | Lvmh Rech | USE OF AN EXTRACT OF ERIOBOTRYA JAPONICA, ESPECIALLY IN THE FIELD OF COSMETICS, TO STIMULATE THE SYNTHESIS OF GLYCOSAMINOGLYCANS. |
| FR2742987A1 (en) * | 1996-01-03 | 1997-07-04 | Lvmh Rech | USE IN THE FIELD OF COSMETICS AND PHARMACY, IN PARTICULAR DERMATOLOGY, OF AN EXTRACT FROM ERIOBOTRYA JAPONICA FOR STIMULATING THE SYNTHESIS OF GLYCOSAMINOGLYCANS |
| WO1997006659A3 (en) * | 1996-01-03 | 1997-10-23 | Lvmh Rech | Use of an eriobotrya japonica extract |
| DE19780092B3 (en) * | 1996-01-03 | 2012-05-24 | Lvmh Recherche | Use of an extract of Eriobotrya japonica, in particular in the field of cosmetics for stimulating the synthesis of glycosaminoglycans |
| JPH1036279A (en) * | 1996-07-18 | 1998-02-10 | Ichimaru Pharcos Co Ltd | Fibroblast proliferation promoting agent containing vegetable extract |
| KR100281001B1 (en) * | 1998-04-22 | 2001-02-01 | 김윤종 | Method of manufacturing skin replenishment liquid based on ginseng |
| KR100358590B1 (en) * | 2000-07-10 | 2002-10-25 | 로제화장품 주식회사 | Cosmetic composition including bupleurum and/or plunus abstracts |
| KR20020012915A (en) * | 2000-08-09 | 2002-02-20 | 유상옥,송운한 | Persicae Flos extract-containing composition for skin-protection against UV |
| JP2002226385A (en) * | 2001-02-01 | 2002-08-14 | Mareyoshi Sawaguchi | Medicine composition for oral cavity and external use |
| EP3058945A3 (en) * | 2015-02-19 | 2016-09-21 | Hiantis S.r.l. | Pharmaceutical compositions and formulations for topical application with astringent and antimicrobial effect |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3483988B2 (en) | Skin preparation | |
| JP3344822B2 (en) | External preparation for skin | |
| JP3122167B2 (en) | Artemisia extract and use thereof | |
| JP2002080338A (en) | Antiaging skin care preparation | |
| JP2937446B2 (en) | Blackening agent to prevent gray hair | |
| JP2025083496A (en) | Cosmetic compositions comprising sucrose esters and solvents | |
| JPH11322630A (en) | Antimicrobial agent, skin external preparation and skin cleansing agent containing same | |
| JP2004002289A (en) | Parakeratosis inhibitor | |
| JPH07215839A (en) | Skin external agent | |
| JPH0995432A (en) | Preparation for external use for skin | |
| JP4828077B2 (en) | Topical skin preparation | |
| JPH11246337A (en) | Anti-aging agent | |
| JPH05301812A (en) | Skin external preparation | |
| JPH09286709A (en) | Preparation for external use for skin | |
| JP2594173B2 (en) | External preparation for skin | |
| JPH11269096A (en) | Preparation composition for external use | |
| JPH0995411A (en) | Preparation for external use for skin | |
| JPH09255551A (en) | Skin preparation for external use | |
| JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
| JPH115725A (en) | Preparation for external use for skin | |
| JPH10273413A (en) | External preparation for skin | |
| JPH07215832A (en) | Skin external preparation | |
| JPH09263514A (en) | Preparation for external use for skin | |
| JPH05112442A (en) | External preparation of skin | |
| JPH08268866A (en) | Dermal preparation for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20030430 |